StockData
Regen BioPharma Inc logo

Regen BioPharma Inc (RGBP) stock

RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)

Close on Oct 19, 2026Market cap $92.33KP/E –Yield –

Regen BioPharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Regen BioPharma's total debt was $0 at Jun 30, 2024. For fiscal 2023 it was $149.61K.

Annual total debt

PeriodPeriod endValueChange
FY2023Sep 30, 2023$149.61K–
FY2022Sep 30, 2022$0-100.0%
FY2016Sep 30, 2016$107.06K–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2024CQ2 2024Jun 30, 2024$0–
Q2 FY2024CQ1 2024Mar 31, 2024$143.69K+34.2%
Q1 FY2024CQ4 2023Dec 31, 2023$153.98K–
Q4 FY2023CQ3 2023Sep 30, 2023$149.61K–
Q4 FY2022CQ3 2022Sep 30, 2022$0–
Q4 FY2016CQ3 2016Sep 30, 2016$107.06K–

More Regen BioPharma figures

See a number that looks wrong?